Login / Signup

Long-term changes of choroidal blood flow velocity in Vogt-Koyanagi-Harada disease.

Shinya AbeTomoko NakamuraErika OkumuraToshihiko OiwakeAnnabelle A OkadaAtsushi Hayashi
Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)
With initiation of corticosteroid treatment in VKH disease patients, choroidal blood flow improved and was maintained for 2 years. However, the presence of SGF should be taken into consideration when interpreting MBR results in VKH disease patients.
Keyphrases
  • blood flow
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • combination therapy
  • optic nerve